New, Simpler Treatment Guidelines Could Save Heart Attack Patients
A UC physician is the lead author of new, simplified guidelines designed to help physicians treat and prevent heart attacks.
The original guidelines, issued by the American College of Cardiology (ACC) and the American Heart Association (AHA), tell emergency department physicians how to recognize early symptoms of heart attack, and what to do next.
The problem, said Brian Gibler, MD, chairman of UCs Department of Emergency Medicine, is that navigating the daunting 95 pages of the complete ACC/AHA guidelines probably leaves them underused.
Now, in the August edition of the Annals of Emergency Medicine, Dr. Gibler and other national emergency medicine and cardiology experts provide a distilled review of the ACC/AHA guidelines.
Its critical that physicians know how to determine whether an emergency patient with chest pain is at high or low risk of a heart attack, Dr. Gibler said. If used, the review will help physicians diagnose acute coronary events quicker, and provide faster treatment that may even prevent a heart attack or damage to the heart before it happens.
Each year, more than 5.3 million patients are treated in hospital emergency departments for chest pains. The challenge, Dr. Gibler points out, is for doctors to quickly identify those who are at highest risk for a heart attack.
The Annals of Emergency Medicine is the official scientific journal of the American College of Emergency Physicians.
Dr. Giblers co-authors were Christopher Cannon, Brigham & Womens Hospital; Andra Blomkalns, University of Cincinnati; Douglas Char, Washington University; Barbara Drew, University of CaliforniaSan Francisco; Judd Hollander, University of Pennsylvania; Allan Jaffe, Mayo Clinic; Robert Jesse, Department of Veterans Affairs; Kristin Newby, Duke University; Magnus Ohman, University of North Carolina; Eric Peterson, Duke University; and Charles Pollack, University of Pennsylvania.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.